Related Experiment Video

Updated: Aug 28, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Replication-incompetent adenoviruses as vectors for protective immunization against measles virus infection

C Schindler1, A Fooks, J Stephenson

  • 1Institut für Virologie und Immunobiologie, Universität Würzburg, Germany.

Behring Institute Mitteilungen
|December 1, 1994
PubMed

Insights

A novel recombinant adenovirus vaccine (RAd) shows promise for measles prevention. In rats, this vaccine candidate effectively protected against lethal measles virus challenge, demonstrating complete immunity and rapid virus elimination.

Area of Science:

  • Virology
  • Vaccinology
  • Immunology

Background:

  • Measles causes significant global mortality, especially in developing nations.
  • Existing live-attenuated vaccines face challenges, necessitating new approaches.
  • A novel vaccine strategy is crucial for controlling measles outbreaks.

Purpose of the Study:

  • To evaluate a replication-incompetent adenovirus vector vaccine (RAd) expressing measles virus genes.
  • To characterize the cell-mediated and humoral immune responses induced by the RAd vaccine.
  • To assess the protective efficacy of the RAd vaccine against experimental measles virus infection.

Main Methods:

  • Development of a recombinant adenovirus vector (RAd) expressing measles virus genes under CMV promoter control.
  • Immunization of a rat model with the candidate RAd vaccine.
  • Challenge with a lethal dose of measles virus to assess protection.
  • Monitoring for disease signs, histopathological changes, and virus elimination.

Main Results:

  • RAd68-immunized rats showed no signs of measles disease or pathology after lethal virus challenge.
  • Complete elimination of measles virus was observed within days post-challenge.
  • The defective recombinant adenovirus vector successfully induced complete protection in the animal model.

Conclusions:

  • Defective recombinant adenovirus vectors represent a viable platform for developing effective measles vaccines.
  • This RAd vaccine candidate demonstrated complete protection against experimental measles infection in rats.
  • Further development of this adenovirus-based vaccine strategy holds potential for global measles control.

More Related Videos

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...